Health Effects of the CPT1A P479L Variant: Responsible Public Health Policy
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Ohle K, Koller K, Walch A, Lee F, Palmer L, Nu J Fam Community Health. 2023; 46(4):250-258.
PMID: 37703513 PMC: 10502956. DOI: 10.1097/FCH.0000000000000370.
References
1.
Bonnefont J, Djouadi F, Prip-Buus C, Gobin S, Munnich A, Bastin J
. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med. 2004; 25(5-6):495-520.
DOI: 10.1016/j.mam.2004.06.004.
View
2.
Gessner B, Gillingham M, Johnson M, Richards C, Lambert W, Sesser D
. Prevalence and distribution of the c.1436C→T sequence variant of carnitine palmitoyltransferase 1A among Alaska Native infants. J Pediatr. 2010; 158(1):124-9.
DOI: 10.1016/j.jpeds.2010.07.031.
View
3.
Gessner B, Wood T, Johnson M, Richards C, Koeller D
. Evidence for an association between infant mortality and homozygosity for the arctic variant of carnitine palmitoyltransferase 1A. Genet Med. 2016; 18(9):933-9.
PMC: 4965343.
DOI: 10.1038/gim.2015.197.
View
4.
Rajakumar C, Ban M, Cao H, Young T, Bjerregaard P, Hegele R
. Carnitine palmitoyltransferase IA polymorphism P479L is common in Greenland Inuit and is associated with elevated plasma apolipoprotein A-I. J Lipid Res. 2009; 50(6):1223-8.
PMC: 2681405.
DOI: 10.1194/jlr.P900001-JLR200.
View
5.
Bonnefont J, Specola N, Vassault A, Lombes A, Ogier H, De Klerk J
. The fasting test in paediatrics: application to the diagnosis of pathological hypo- and hyperketotic states. Eur J Pediatr. 1990; 150(2):80-5.
DOI: 10.1007/BF02072043.
View